ARGA Investment Management LP Has $57.74 Million Position in Humana Inc. $HUM

ARGA Investment Management LP increased its position in shares of Humana Inc. (NYSE:HUM) by 311.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 221,917 shares of the insurance provider’s stock after buying an additional 167,926 shares during the period. Humana accounts for approximately 1.5% of ARGA Investment Management LP’s holdings, making the stock its 17th biggest position. ARGA Investment Management LP’s holdings in Humana were worth $57,736,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the business. Elevation Point Wealth Partners LLC acquired a new stake in Humana during the second quarter worth about $32,000. Mather Group LLC. bought a new stake in Humana in the third quarter valued at $34,000. AlphaCore Capital LLC bought a new stake in shares of Humana in the 2nd quarter worth about $39,000. Private Wealth Management Group LLC increased its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares in the last quarter. Finally, SJS Investment Consulting Inc. increased its holdings in Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 193 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Humana stock opened at $265.68 on Friday. The business’s 50-day moving average price is $258.26 and its two-hundred day moving average price is $264.47. The stock has a market cap of $31.95 billion, a PE ratio of 24.90, a P/E/G ratio of 2.19 and a beta of 0.45. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The firm had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $4.16 earnings per share. As a group, analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s dividend payout ratio is currently 33.18%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HUM. The Goldman Sachs Group lowered their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a report on Monday, November 24th. Bank of America boosted their price target on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Barclays reaffirmed an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Wells Fargo & Company cut Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Finally, Jefferies Financial Group raised shares of Humana from a “hold” rating to a “buy” rating and boosted their price target for the stock from $253.00 to $313.00 in a research report on Friday, December 5th. Eight equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $293.37.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.